Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                                  Dated:20 October,2019

Johnson & Johnson voluntarily recalls products for asbestos

The U.S. Food and Drug Administration is alerting consumers of a voluntary recall by Johnson & Johnson of Johnson’s Baby Powder after FDA testing has found that a sample from one lot of the product contains chrysotile fibers, a type of asbestos. Consumers who have Johnson’s Baby Powder lot #22318RB should stop using it immediately and contact Johnson & Johnson for a refund. The FDA stands by the quality of its testing and results and is not aware of any adverse events relating to exposure to the lot of affected products.

During talc mining, if talc mining sites are not selected carefully and steps are not taken to purify the talc ore sufficiently, the talc may be contaminated with asbestos. Asbestos is a known carcinogen. It is important to note that the FDA has been conducting testing of talc-containing cosmetic products for asbestos. Not all talc contains asbestos and the majority of product samples tested by the FDA did not contain asbestos… (US FDA, Oct. 18, 2019)


100 Mohalla Clinics opened in Delhi
A Mohalla Clinic model is being showcased live at the 26th Perfect Health Mela

100 Mohalla Clinics opened in Delhi yesterday. Now there are more than 300 Mohalla Clinics operating in Delhi since the first Mohalla Clinic was opened in 2015.

The concept of Mohalla Clinic was started by the Delhi Government to provide primary healthcare to all. As part of a four-tier health care delivery system, these clinics have been conceptualized as the first point of contact for the public, which provide basic quality primary health care services including medicines, diagnostics and consultation free of cost. This also reduces the load on secondary and tertiary hospitals. ....read more


(Excerpts from NIH, Oct. 16, 2019): A multicenter randomized clinical trial evaluating a new artificial pancreas system has found that the new system was more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes. The research is published in the New England Journal of Medicine.
The NIH-funded study of people with type 1 diabetes showed that the system improved participants’ blood glucose control throughout the day and overnight.

The International Diabetes Closed-Loop (iDCL) Study involves five separate artificial pancreas clinical protocols implemented by 10 research centers in the United States and Europe. ....read more


Significance of Lighting a Lamp in Any Worship
Deepajyothi parabrahma
Deepa Jyotir Janaardanah
Deepo harati paapaani
Sandhyaa deepa namostute ....read more

Healthcare News Monitor

All medical devices to be regulated from December 1
TNN-Sushmi Dey

NEW DELHI: The health ministry has proposed to notify all medical devices from December 1, expanding the span of regulation to ensure safety and efficacy of a variety of such products used for diagnosis, treatments and other medical interventions in human beings and even in animals. The ministry published a gazette notification on Friday with the proposal defining all medical devices as drugs and seeking public comments within one month. It later also notified a separate set of draft rules under which these devices will be regulated once the final notification is issued. Once the final notification is in place, all medical devices including software, equipments, accessories and contraceptives will be regulated under Drugs and Cosmetics Act and firms will have to seek an approval from the Drugs Controller General of India to manufacture, import and sell any medical devices in the country.

Food regulator asks sweet manufacturers to ensure quality
Wilson Thomas

The Food Safety and Standards Authority of India (FSSAI) has advised bakery and sweets manufacturers to prepare and stock adulterant-free and safe confectioneries for this Deepavali. At meeting held for confectioners here on Tuesday, the food regulator has stressed them to use minimal colours in sweets. Samples of sweets made with minimal colours and those made with high concentration of colourants were displayed at the meeting for better understanding. K. Tamilselvan, Designated Officer of FSSAI, Coimbatore, said that the focus of the meeting was to educate confectioners on good practices to be followed in the manufacturing of sweets from the selection of raw materials to the packing and the storage. Colouring agents permitted by the FSSAI should be used for manufacturing sweets that require colour. The permitted colours should not be used beyond the prescribed level, not more than 100mg for 1 kg of sweets or 100 PPM (parts per million) of the item. Vanaspati should not be used instead of ghee for ghee-based sweets. Only packaged cooking oil should be used for making sweets. “The confectioners were asked to avoid banned plastic products for packing sweets. The package should have proper label which include FSSAI licence/registration number, the name and address of the manufacturer, dates of manufacture and expiry, price and ingredients. Milk-based products that have short shelf life should be stored separately while stocking”, he added. Employees at the manufacturing units and shops should wear proper clothing and should have hygiene gears like glove, cap and face mask. Newspaper should not be used for storing or packaging purposes.

184 Hit by Dengue Admitted in Coimbatore Govt Hospital as Tamil Nadu Sees Rise in Cases
News18

The onset of southwest monsoon has seen a widespread rise in mosquito-borne diseases like malaria and dengue in Tamil Nadu. In face of the crisis, the government hospitals have come up with special wards to treat mosquito-borne diseases and flu. The number of in-patients affected by the flu in Coimbatore Government Hospital, has been increasing day by day. As many as 184 patients have been undergoing treatment for flu-like dengue, viral fever, and malaria at the Hospital, which has created a panic-like situation among the people. Besides, the number of affected people admitted in private hospitals has not yet been taken stock of by the government. Apart from Coimbatore, five people in Kanyakumari, 14 in Madurai Rajaji Government Hospital, four in Aruppukottai, three in Thanjavur and two each in Trichy and Karur have been identified to be affected with dengue and are currently undergoing treatment at State-owned hospitals. Thoothukudi Government College and Hospital, State Health Minister C Vijayabaskar said about 10 percent of the patients consulting for fever at government hospitals have dengue symptoms. He further added that the monsoon season will be challenging but they are ready to face any situation and people should not worry.

Delhi tops Union Territories in NITI Aayog’s innovation index
Hindustan Times

Among Union territories, Delhi has topped the chart in the Niti Aayog’s innovation index, the first-ever innovation ranking of states, released on Thursday by the government think tank’s vice chairman Rajiv Kumar and chief executive officer Amitabh Kant. The ranking was done in three categories -- ‘Major States’, ‘North East and Hill States’ and ‘Union Territories (UTs)/City and Small States’. “The index shows that the innovation ecosystem of the country is strong in south and western parts of India. In fact, three of the top five major states are from southern India. Delhi and Haryana seem to be an exception to this rule and seem to be doing well on the Index. Thus, there seems to be a west-south and north-east divide across the country,” the report stated. Telangana, Haryana, Kerala, Uttar Pradesh, West Bengal, Gujarat and Andhra Pradesh were among the toppers in the states category. Delhi also featured in the list of most efficient states/UTs in “translating inputs into output”. The report, which has captured trends and done deep-drive analyses of various factors that drive innovation at the country, state and pillar levels, envisages to help policymakers and corporates identify some of the issues at a sustainable level in India.
The index has been grouped under two major heads, enablers -- factors that will drive innovation in states and UTs, and performance -- that will measure the actual outcomes in the innovation competitiveness of states.